Free Hemoglobin

Dark urine can come from urinary tract bleeding, muscle injury, or red cells breaking down in the bloodstream. Urine free hemoglobin measures the oxygen-carrying protein after it has been released from red cells. But those cells can also break open within the urinary tract or after collection, so the result alone cannot establish where the breakdown happened.

Hemoglobin in urine is an established clue when investigating red cell destruction. The concentration has a less established role as a measure of future kidney risk or treatment response, and screening healthy people with this test has no demonstrated benefit. This test reports a urine concentration in mg/dL; research using plasma hemoglobin or a urine dipstick does not directly validate that number.

How Hemoglobin Ends Up in Urine

Red cell destruction inside blood vessels is called intravascular hemolysis. Released hemoglobin binds to haptoglobin in the blood. Haptoglobin carries it to cells that remove the bound proteins, and the resulting complex is too large to pass readily through the kidney's filters.

Unbound hemoglobin can separate into smaller units that pass through those filters. Cells lining the kidney's small drainage tubes take up some of the filtered protein. Urinary loss becomes more likely when binding and reabsorption cannot keep up, but the amount also depends on kidney function, urine concentration, and timing. A negative urine result cannot exclude ongoing or recent hemolysis, and a positive result does not prove that haptoglobin has been completely used up.

Kidney Injury

Free hemoglobin can injure kidneys when exposure is substantial. Heme is the iron-containing part of the protein. Animal experiments and studies of cells grown in the laboratory show that hemoglobin and released heme can damage cell membranes and kidney tubule cells. Hemoglobin-containing deposits can also form casts that obstruct the tubules.

Human biopsies show that this injury occurs in clinical disease. A series of 27 kidney biopsies identified hemoglobin casts in people with acute kidney injury from several causes of hemolysis, including immune disorders and transfusion reactions. Because everyone in that series already had kidney injury, it cannot tell you the chance of kidney damage from a particular urine concentration.

Much of the broader evidence concerns plasma free hemoglobin. In 107 adults with severe falciparum malaria, higher plasma concentrations were associated with acute kidney injury. The association with needing dialysis was found for chemical markers of damage to cell membranes. These findings support concern about hemolysis during severe illness but do not establish a urine hemoglobin target.

Sickle Cell Disease

Sickle cell disease can cause ongoing intravascular hemolysis. In two adult cohorts, people carrying two APOL1 kidney-risk variants had hemoglobinuria more often than those without that combination. Hemoglobinuria in these genetic comparisons was defined from urinalysis findings, not from a quantified free hemoglobin level.

A substudy of 25 adults with sickle cell disease, reported in the same paper, did measure urine cell-free hemoglobin. Higher concentrations were moderately associated with higher urine KIM-1. KIM-1 is a protein released by injured kidney tubule cells. This supports a connection with kidney injury, but it does not establish a treatment target or show that this catalog test gives interchangeable results.

PNH and Other Hemolytic Disorders

PNH is short for paroxysmal nocturnal hemoglobinuria. It is an acquired blood disorder in which red cells become vulnerable to complement. Complement is a group of immune proteins that can destroy these cells inside blood vessels. Other causes of intravascular hemolysis include some immune reactions, incompatible transfusions, infections, and damage from mechanical blood pumps.

In a multicenter study of 3,938 samples referred for PNH screening, about half of those submitted because of hemoglobinuria contained PNH-type blood cells. That was a selected group already considered suspicious for disease, so the percentage is not your chance of having PNH after an unexpected urine result. Diagnosis requires specialized testing of blood cells.

What Dipstick Studies Can Establish

IgA nephropathy causes immune deposits and inflammation in the kidney's filters. In a retrospective study of 441 people with biopsy-proven disease, dipstick blood was associated with active inflammatory changes on biopsy, but not with chronic scarring. A dipstick detects pigment from intact red cells, free hemoglobin, and muscle-derived myoglobin. The finding does not establish that quantitative urine free hemoglobin can identify inflammation or guide treatment.

A small study also examined urine blood findings in children with Shiga toxin-producing E. coli infection. Among 63 children being followed after bloody diarrhea that tested positive for Shiga toxin 2, all 15 who developed hemolytic uremic syndrome had a positive urine blood finding; seven other children with a positive finding did not develop the syndrome. This syndrome involves red cell destruction, low platelets, and kidney injury. The study used dipstick and urinalysis findings rather than this quantitative assay, and its results do not justify using a negative urine result to dismiss concerning symptoms.

Severe Infection

In 391 critically ill people with sepsis, the median plasma free hemoglobin concentration was about twice as high among those who died as among survivors, and the association remained after adjustment for other factors. This was an observational study of blood, not urine. It does not establish that a urinary concentration predicts survival or that lowering this urine result improves outcomes.

When Results Can Be Misleading

• Urinary tract bleeding or menstrual contamination: red cells from these sources can release real hemoglobin into urine. That is a different explanation from destruction inside the bloodstream.
• Cell breakdown after collection: red cells can rupture in the sample, especially in dilute urine. Delayed processing can leave free hemoglobin with few intact cells on microscopy, making the source harder to identify.
• Urine concentration and timing: the reported concentration changes with dilution, and intermittent hemolysis may be missed between episodes. A change in the number does not necessarily mean the same change in red cell destruction.
• Muscle pigment and assay differences: myoglobin can produce a positive urine blood dipstick. Whether it interferes with this quantitative test depends on the laboratory's method, which is not specified in the catalog.
• Exercise and recent procedures: endurance exercise can cause temporary urinary bleeding, hemolysis, or muscle injury. Heart procedures and stem cell infusions can also cause acute hemolysis. These findings need context and should not automatically be treated as a harmless exercise effect.
• Medications associated with bleeding: anticoagulants, aspirin, and some chemotherapy drugs can contribute to urinary tract bleeding. This can introduce hemoglobin without intravascular hemolysis, but it does not remove the need to investigate the bleeding.

Tracking Your Trend

In a known hemolytic disorder, repeated urine measurements may add context to symptoms and blood results. There is no validated percentage change in urine free hemoglobin that, by itself, establishes improvement, worsening disease, or inadequate drug dosing. Blood tests for red cell destruction and new red cell production usually provide the main monitoring evidence. LDH is an enzyme released by damaged cells and is one of the blood markers used for this purpose.